Sort   by:  
 Page size 
UnknownRisk Factors and Outcome of HHV-6 Infections After Allogeneic Hematopoietic Cell Transplantation.
Not available
S-EPMC12272341 | biostudies-literature
UnknownCichorium intybus L. Hairy Roots as a Platform for Antimicrobial Activity
Not available
S-EPMC9967317 | biostudies-literature
UnknownAberrant localization and underglycosylation of highly accumulating single-chain Fv-Fc antibodies in transgenic Arabidopsis seeds.
Not available
S-EPMC1783127 | biostudies-literature
UnknownImmunophenotypic changes in the tumor and tumor microenvironment during progression to multiple myeloma.
Not available
S-EPMC12558612 | biostudies-literature
UnknownDasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION).
Not available
S-EPMC4916556 | biostudies-literature
UnknownA randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS).
Not available
S-EPMC5220126 | biostudies-literature
UnknownA pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis.
Not available
S-EPMC4800694 | biostudies-literature
Sort   by:  
 Page size